Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis
作者:Hazem Elkady、Khaled El‐Adl、Helmy Sakr、Adel S. Abdelraheem、Sally I. Eissa、Mohamed Ayman El‐Zahabi
DOI:10.1002/ardp.202300097
日期:2023.9
synthesized to obtain new effective antitumor immunomodulatory agents. The synthesized compounds were evaluated for their cytotoxic activities against HepG-2, HCT-116, PC3, and MCF-7 cells. Generally, the open analogs with semicarbazide and thiosemicarbazide moieties (10, 13a–c, 14, and 17a,b) exhibited higher cytotoxic activities than derivatives with closed glutarimide moiety (8a–d). In particular, compound
设计并合成了11种新型苯并恶唑/苯并噻唑基沙利度胺类似物,以获得新的有效抗肿瘤免疫调节剂。评估了合成化合物对 HepG-2、HCT-116、PC3 和 MCF-7 细胞的细胞毒活性。一般来说,具有氨基脲和氨基硫脲部分的开放类似物(10、13a -c、14和17a,b )比具有封闭戊二酰亚胺部分的衍生物(8a-d)表现出更高的细胞毒性活性。特别是,化合物13a(针对 HepG-2、HCT-116、PC3 和 MCF-7 的 IC 50 分别为 6.14、5.79、10.26 和 4.71 µM)和 14(IC 50 = 7.93、8.23、12.37 和 5.43) µM)对四种测试细胞系表现出最高的抗癌活性。进一步评估了最具活性的化合物13a和14对肿瘤坏死因子-α (TNF-α)、caspase-8 (CASP8)、血管内皮生长因子 (VEGF) 和核因子 kappa-B p65 的体外免疫调节活性HCT-116